Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy.
about
Do bisphosphonates cause femoral insufficiency fractures?Adipose tissue dysfunction and its effects on tumor metabolismLong-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension.Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group ReportRisk factors associated with sacral stress fractures: a systematic review.Atypical femur fractures: a review of the evidence and its implication to clinical practiceBisphosphonates for the treatment of osteoporosis: insights for clinicians.Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study.Spectroscopic markers of bone quality in alendronate-treated postmenopausal womenManagement of osteoporosis among the elderly with other chronic medical conditionsClodronic acid formulations available in Europe and their use in osteoporosis: a review.Adverse effects of bisphosphonates.Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.Fracture risk associated with chronic use of bisphosphonates: evidence today.Safety of long-term bisphosphonate therapy for the management of osteoporosis.Review: epidemiology and pathophysiology of atypical femur fractures.A low-energy femoral shaft fracture from performing a yoga postureLow-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.
P2860
Q27021396-AC4F27AF-7751-4CA6-A0A0-B032F66DE3E8Q28080748-D41CB6CF-5C44-4EBE-AB15-837682C04B42Q34041189-4055EF8D-F873-405F-AB7D-026200835140Q34395462-F76490DC-5730-4576-87AA-DF7B66BF5C29Q34486831-BDE1A063-BF9C-473E-AD3D-B1D443E52839Q35708108-8348257E-7B44-4423-B603-768B9ABAC16FQ36059445-82C0311B-A3DA-455F-8B04-F55BFC9AF00FQ36443681-4A41F617-D100-4E5C-8036-3340205F24C6Q36584072-2732DFBA-A33B-446C-91DC-5467F62A0FD4Q37149051-8A8D65A2-8641-4E30-A7E3-68C07BC8E48AQ37156112-ED1CD0A4-5D51-4ACB-9DE8-33080A0938B2Q37477158-86C5728F-54B6-4BB2-8DCB-EDDFA2C30078Q37734906-782DE76C-A07B-448D-80C9-348395EA3A63Q37738185-34C63E55-9BEA-4900-923B-7070477918BDQ37814414-5C1789FE-0A0B-4D0A-BC9C-936A40EBE958Q37866764-DEA9DEA1-A041-466E-A9C6-304E5B174429Q38187901-4B033C3B-453B-4D67-951A-04F92E02F510Q42163178-BE3E1525-B544-4449-A081-770410674B0FQ43294074-3F035FA9-69A3-446B-9D39-6F0304C81D35
P2860
Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Looking beyond low bone minera ...... orosis on alendronate therapy.
@en
type
label
Looking beyond low bone minera ...... orosis on alendronate therapy.
@en
prefLabel
Looking beyond low bone minera ...... orosis on alendronate therapy.
@en
P2093
P2860
P356
P1476
Looking beyond low bone minera ...... orosis on alendronate therapy.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03346353
P577
2007-07-01T00:00:00Z